Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

Queensland Centre for Medical Genomics, Institute of Molecular Biosciences

Brisbane, Queensland AUSTRALIA

Magenta Marker Queensland Centre for Medical Genomics, Institute of Molecular Biosciences

University of Queensland
St Lucia QLD 4072
+617 3346 2392
www.qcmg.org

The Queensland Centre for Medical Genomics is committed to deliver and enable personalized medicine for the state of Queensland and Australia

The centre’s flagship project is the sequencing of 500 Pancreatic and Ovarian cancer genomes as part the International Cancer Genome Consortium (ICGC).  

Australia’s commitment to the ICGC has required the formation of this world class sequencing centre within the Institute for Molecular Bioscience (IMB), University of Queensland (UQ) and currently employs 38 bioinformaticians and molecular biology research scientists dedicated to medical genome research.


-27.4978543 153.0132861

University of Queensland
St Lucia QLD 4072
+617 3346 2392
www.qcmg.org

The Queensland Centre for Medical Genomics is committed to deliver and enable personalized medicine for the state of Queensland and Australia

The centre’s flagship project is the sequencing of 500 Pancreatic and Ovarian cancer genomes as part the International Cancer Genome Consortium (ICGC).  

Australia’s commitment to the ICGC has required the formation of this world class sequencing centre within the Institute for Molecular Bioscience (IMB), University of Queensland (UQ) and currently employs 38 bioinformaticians and molecular biology research scientists dedicated to medical genome research.